IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

被引：132

作者：

Perrier, Stephane

Darakhshan, Froogh

Hajduch, Eric ^{[1
]}

机构：

[1] INSERM, U755 Nutrion, F-75006 Paris, France

[2] Univ Paris 06, F-75005 Paris, France

[3] Univ Dundee, Sch Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland

来源：

FEBS LETTERS | 2006年 / 580卷 / 27期

关键词：

interleukin-1 receptor antagonist; diabetes; obesity; insulin resistance; gene polymorphism; adipocyte;

D O I：

10.1016/j.febslet.2006.10.061

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Interleukin-1 receptor antagonist (IL-1ra) has been shown to play a crucial role in the prevention of various inflammatory diseases. There is also convincing evidence that IL-1ra is able to counteract inflammatory effects of IL-1 members implicated in insulin resistance and diabetes. However, the use of knock-out animal models provides evidence to the contrary and the role of IL-1ra in obesity-linked anomalies remains controversial. This minireview gets an insight into recent findings on the implication of IL-1ra and its gene polymorphism in diabetes and obesity, discusses the potential dual effects of IL-1ra observed in different models, and comments on future directions. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：6289 / 6294

页数：6

共 74 条

[1] The balance between IL-1 and IL-1Ra in disease
Arend, WR
[J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) : 323 - 340
[2] A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development
Bar, D
Apte, RN
Voronov, E
Dinarello, CA
Cohen, S
[J]. FASEB JOURNAL, 2004, 18 (01) : 161 - 163
[3] Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4
[4] Blakemore AIF, 1996, HUM GENET, V97, P369, DOI 10.1007/BF02185776
[5] CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
[6] HUMAN DERMAL FIBROBLAST INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) AND INTERLEUKIN-1-BETA (IL-1-BETA) MESSENGER-RNA AND PROTEIN ARE CO-STIMULATED BY PHORBOL ESTER - IMPLICATION FOR A HOMEOSTATIC MECHANISM
CHAN, LS
HAMMERBERG, C
KANG, K
SABB, P
TAVAKKOL, A
COOPER, KD
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (03) : 315 - 322
[7] DYSREGULATION OF THE IN-VIVO PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN PATIENTS WITH RHEUMATOID-ARTHRITIS - PATHOGENETIC IMPLICATIONS
CHIKANZA, IC
ROUXLOMBARD, P
DAYER, JM
PANAYI, GS
[J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (05): : 642 - 648
[8] Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6
Daig, R
Rogler, G
Aschenbrenner, E
Vogl, D
Falk, W
Gross, V
Schölmerich, J
Andus, T
[J]. GUT, 2000, 46 (03) : 350 - 358
[9] Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis
Dewberry, R
Holden, H
Crossman, D
Francis, S
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) : 2394 - 2400
[10] Biologic basis for interleukin-1 in disease
Dinarello, CA
[J]. BLOOD, 1996, 87 (06) : 2095 - 2147

← 1 2 3 4 5 6 7 8 →